ATE203749T1 - Verfahren zur herstellung amorphen paroxetin- hydrochlorids - Google Patents

Verfahren zur herstellung amorphen paroxetin- hydrochlorids

Info

Publication number
ATE203749T1
ATE203749T1 AT97108713T AT97108713T ATE203749T1 AT E203749 T1 ATE203749 T1 AT E203749T1 AT 97108713 T AT97108713 T AT 97108713T AT 97108713 T AT97108713 T AT 97108713T AT E203749 T1 ATE203749 T1 AT E203749T1
Authority
AT
Austria
Prior art keywords
paroxetine hydrochloride
amorphic
producing
producing amorphic
hydrochloride
Prior art date
Application number
AT97108713T
Other languages
English (en)
Inventor
Shu-Zhong Wang
Takashi Okazoe
Yasushi Matsumura
Original Assignee
Asahi Glass Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Glass Co Ltd filed Critical Asahi Glass Co Ltd
Application granted granted Critical
Publication of ATE203749T1 publication Critical patent/ATE203749T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
AT97108713T 1996-05-30 1997-05-30 Verfahren zur herstellung amorphen paroxetin- hydrochlorids ATE203749T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13719296 1996-05-30

Publications (1)

Publication Number Publication Date
ATE203749T1 true ATE203749T1 (de) 2001-08-15

Family

ID=15192956

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97108713T ATE203749T1 (de) 1996-05-30 1997-05-30 Verfahren zur herstellung amorphen paroxetin- hydrochlorids

Country Status (6)

Country Link
US (2) US20010021776A1 (de)
EP (2) EP0810224B1 (de)
AT (1) ATE203749T1 (de)
CA (1) CA2206592A1 (de)
DE (1) DE69705896T2 (de)
ES (1) ES2160871T3 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638948B1 (en) * 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
CA2193939C (en) * 1996-12-24 2002-02-12 K.S. Keshava Murthy Useful form of anhydrous paroxetine hydrochloride
EP0952831A1 (de) * 1997-01-15 1999-11-03 Smithkline Beecham Plc Paroxetinhaltige arzneizubereitungen
WO1998056787A1 (de) 1997-06-10 1998-12-17 Synthon B.V. 4-Phenylpiperidin-Derivate
IL137684A0 (en) * 1998-02-06 2001-10-31 Smithkline Beechmam Plc Salts of paroxetine
GB9806312D0 (en) * 1998-03-24 1998-05-20 Smithkline Beecham Plc Novel formulations
US6168805B1 (en) 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
GB9814316D0 (en) * 1998-07-02 1998-09-02 Smithkline Beecham Plc Novel compounds
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
ES2138937B1 (es) 1998-07-07 2000-10-01 Medichem Sa Polimorfo de maleato de paroxetina y formulaciones farmaceuticas que lo contienen.
WO2000008016A1 (en) * 1998-08-08 2000-02-17 Smithkline Beecham Plc Paroxetine salts
GB9824298D0 (en) * 1998-11-05 1998-12-30 Smithkline Beecham Plc Novel process
GB9826180D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
IN191492B (de) * 1999-05-25 2003-12-06 Ranbaxy Lab Ltd
GB9914600D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel,process
DK1109806T3 (da) 1999-07-01 2003-12-22 Italfarmaco Spa Komplekser af paroxetin med cyclodextriner eller cyclodextrinderivater
HU226912B1 (en) * 2000-04-07 2010-03-01 Richter Gedeon Nyrt New paroxetin salt and medicament containing it
WO2002022609A1 (fr) * 2000-09-14 2002-03-21 Asahi Glass Company, Limited Procede de production de sel de paroxetine sensiblement exempt de solvant organique
US20030032809A1 (en) * 2001-04-25 2003-02-13 Subhash P. Upadhyaya Optimized procedures for the manufacture of paroxetine salts
IL159280A0 (en) * 2001-06-14 2004-06-01 Teva Pharma A process for preparing paroxetine hcl which limits formation of pink colored compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
EP0223403B1 (de) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel
EP0542355A1 (de) * 1991-11-15 1993-05-19 Merck Frosst Canada Inc. Amorphe (Chinolin-2-ylmethoxy)Indole als Leukotrien-Antagonisten
IT1274241B (it) * 1993-12-03 1997-07-15 Smithkline Beecham Farma Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono

Also Published As

Publication number Publication date
CA2206592A1 (en) 1997-11-30
ES2160871T3 (es) 2001-11-16
EP1090918A1 (de) 2001-04-11
DE69705896D1 (de) 2001-09-06
EP0810224B1 (de) 2001-08-01
DE69705896T2 (de) 2002-04-11
US20030181725A1 (en) 2003-09-25
US20010021776A1 (en) 2001-09-13
EP0810224A1 (de) 1997-12-03

Similar Documents

Publication Publication Date Title
ATE203749T1 (de) Verfahren zur herstellung amorphen paroxetin- hydrochlorids
ATE359994T1 (de) Verfahren zur herstellung von oxazolidinonen
DE69834673D1 (de) Verfahren zur Herstellung einer Elektronenemittierenden Quelle
NO20016226D0 (no) Fremgangsmåte for fremstilling av substituerte formamider
DE69631298D1 (de) Verfahren zur Herstellung von Paroxetinhydrochloridanhydrat
DE69621297T2 (de) Verfahren zur Herstellung wasserlöslicher organischer Silizium-Verbindungen
DE69609796T2 (de) Verfahren zur herstellung von essigsäure
ATE237604T1 (de) Verfahren zur herstellung von citalopram
DE69313515T2 (de) Verfahren zur Herstellung eines aromatischen Carbonats
DE69900891D1 (de) Verfahren zur herstellung von citalopram
ATA904199A (de) Verfahren zur herstellung von citalopram
DE69709164T2 (de) Verfahren zur herstellung von essigsäure
DE69624825T2 (de) Eintopfverfahren zur herstellung von 2-oxazolidinonderivate
DE69726441D1 (de) Verfahren zur herstellung von 1,3-dioxolan-4-methanol-verbindungen
DE59601895D1 (de) Verfahren zur herstellung von butyrolactonen
DE69909821D1 (de) Verfahren zur herstellung von weichem seidenpapier
DE69701915D1 (de) Verfahren zur Herstellung eines einbügelbaren Einlagestoffs
DE69411575D1 (de) Verfahren zur herstellung lithographischer druckformen
DE69724442D1 (de) Verfahren zur herstellung von 1,3-dioxolan-4-methanol-verbindungen
DE59711748D1 (de) Verfahren zur Herstellung von 3-(1-Hydroxyphenyl-1-alkoximinomethyl)dioxazinen
ATE355268T1 (de) Verfahren zur herstellung von citalopram
DE59510636D1 (de) Verfahren zur herstellung von 8-alpha,12-oxido-13,14,15,16-tetranorlabdan
ATE353937T1 (de) Verfahren zur synthese einer oxonolverbindung
DE69721812T2 (de) Verfahren zur herstellung optisch aktiver 3-quinuclidinol derivate
DE69406004D1 (de) Verfahren zur Herstellung eines verbesserten Bilds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties